Russian President V. Putin signed Federal Law No. 488-FZ, which deals with the amendments to the “Principles of State Regulation of Trading Activities in the Russian Federation”. This article outlines the labeling and management of track and trace data requirements of the new law.
Pharma company finds a solution that allows the operator to conveniently assign the units from a lower packaging level to a higher level and, in this way, to set up the hierarchical relationships in the database.
Serialization and aggregation solutions allows Swiss-based Acino Pharma serve its international customers quickly and reliably
Counterfeit medicines are now a worldwide problem. According to some estimates, more than 10 percent of all drugs in the global supply chain are counterfeit and, in some countries, much higher.
Ropack Pharma Solutions provides a serialized supply chain that is proficient, verified and ready to safeguard your pharmaceutical product and the patients who depend on it.
Serialization solutions enabling easy tractability and tracking of individual product packages.
Fully automated aggregation, compliance with regulations and industry standards, and flexibility and modularity. Solutions for the marking, verification and Code verification of aggregated product packages from carton to crate.
The T2811 Label Serialization Compact prints and inspects labels with serialized data in one integrated system.
Being the starting point in a Track & Trace packaging line, the T2810 provides integrated serialization and ERP connectivity to comply with regulatory requirements. Labels are automatically serialized, and all serialization information is transmitted to your database or ERP system.
Many biopharmaceutical drug formulations have some degree of oxygen sensitivity. Topics for this webinar include how oxygen levels in finished parenteral drug containers can be determined for oxygen scavenger & stability studies, for determining inherent primary packaging integrity, and for optimizing & qualifying inert gas purging system during filling.
When CDMOs understand what motivates drug innovators to outsource, who is involved in the service provider selection decision, and which CDMO attributes have the greatest influence on CDMO selection they are able to communicate what is unique about their offering to the right audience at the right time.
This webinar describes the use of positive controls as an important element of CCI studies designed to validate packaging components for CCI or to qualify processes for producing good CCI.
This webinar presents how to design and conduct studies to assess the total oxygen permeation rate of your pre-filled syringes, and how to determine if the permeation is primarily through the plunger or through the tip. Protecting oxygen-sensitive formulations during filling will also be discussed.
